Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Nucl Med Biol ; 20(2): 133-44, 1993 Feb.
Article in English | MEDLINE | ID: mdl-8448565

ABSTRACT

The therapeutic effects of 125I-labelled (18-97 MBq) monoclonal antibodies (MAb) C-242, C-215 and S-S.1 were studied in nude mice with human colorectal adenocarcinoma tumours. The antibodies were administered 2 or 10-16 days after implantation of the tumour cells. The monoclonal antibody C-242 was internalized into the tumour cells, C-215 was internalized to a lower degree while S-S.1 (unspecific MAb) was not internalized at all. No enhanced therapeutic effect of 125I-C-242 was observed, as a result of Auger electrons, compared with 125I-C-215 and 125I-S-S.1.


Subject(s)
Adenocarcinoma/therapy , Antibodies, Monoclonal/therapeutic use , Colorectal Neoplasms/therapy , Iodine Radioisotopes/therapeutic use , Neoplasms, Experimental/therapy , Animals , Cell Line , Dose-Response Relationship, Radiation , Female , Humans , Injections, Intravenous , Iodine Radioisotopes/administration & dosage , Iodine Radioisotopes/blood , Mice , Mice, Nude , Neoplasm Transplantation , Tissue Distribution
2.
Int J Rad Appl Instrum B ; 19(7): 719-26, 1992 Oct.
Article in English | MEDLINE | ID: mdl-1399691

ABSTRACT

A monoclonal antibody, C-215, against colon cancer, was internally labelled with [75Se]methionine. The biodistribution was studied in tumour-bearing nude mice and compared with the biodistribution of [131I]C-215. The tissue uptake was divided into three parts: antibody bound to the antigen, antibody in the extracellular space and uptake of the released radionuclide. [75Se]C-215 showed a greater amount of antigen-bound antibody in the tumour, but also a greater unspecific uptake both in tumour and normal tissue.


Subject(s)
Antibodies, Monoclonal/metabolism , Colonic Neoplasms/diagnostic imaging , Iodine Radioisotopes , Selenium Radioisotopes , Animals , Antigens, Tumor-Associated, Carbohydrate/analysis , Antigens, Tumor-Associated, Carbohydrate/immunology , Cell Line , Humans , Immunoglobulin G/classification , Immunoglobulin G/metabolism , Mice , Mice, Nude , Neoplasm Transplantation , Radionuclide Imaging , Time Factors , Tissue Distribution , Transplantation, Heterologous
3.
Acta Oncol ; 28(5): 699-703, 1989.
Article in English | MEDLINE | ID: mdl-2590546

ABSTRACT

This experimental study in rats examines the influence of tumour growth and RES function modulation on the kinetics of iodinated MAb IgG1 C241. The study was designed to investigate unspecific accumulation in liver and blood. C241 is raised against human colon adenocarcinoma COLO 205 and reacts with SiLea tumour-associated antigen, also known as tumour-associated antigen 19-9. In 26 rats, 2 micrograms 125I MAb C241 (lodobead labelling method) was given i.v. Blood, organ and tumour content was measured at 0.5, 24, 72 and 144 h. In 61 rats, 10 micrograms 131I MAb C241 (lodogen labelling method) was given i.v. The rats were divided into a non-tumour and a tumour-bearing group and subjected to RES function modulation with Zymosan stimulation or methyl palmitate depression. A syngeneic nitrosoguanidine-induced colonic carcinoma--mean 11 g--was growing in back subcutaneous tissue and hind leg musculature. Serum content of tumour-associated antigen was not found on IRMA testing and tumour content of SiLea ganglioside antigen was found only on lipid binding phase assay. The half-time in blood of iodinated MAb C241 was three days. In-vivo release of iodine was tested by plasma separation on a gel column. More than 90% of the iodine was in the IgG fraction. The activity distribution was almost in equilibrium after 24 h. A tumour/blood activity concentration ratio of 0.5 and liver/blood ratio of 0.3 remained at 72 h and 144 h. Radionuclide accumulation was equally low in the macrophage-rich liver and the kidneys. Tumour-bearing animals had significantly lower blood content (0.37 versus 0.99% g-1) and liver content (0.09 versus 0.31% g-1) at 144 h than non-tumour-bearing rats. The whole body content at 144 h was also lower (24% versus 35% of administered activity) (p = 0.10). Modulation of RES function had no significant influence on the whole body, blood or liver content of 131I MAb C241 activity in non-tumour-bearing animals. In tumour-bearing animals, RES stimulation with Zymosan increased the whole body, liver and blood content of 131I activity. The two tested methods of iodination gave similar results.


Subject(s)
Antibodies, Monoclonal , Iodine Radioisotopes/metabolism , Mononuclear Phagocyte System/physiology , Neoplasms, Experimental/metabolism , Adenocarcinoma/immunology , Animals , Colonic Neoplasms/immunology , Female , Humans , Liver/metabolism , Male , Rats , Rats, Inbred Strains , Zymosan/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...